US-listed cannabis and marijuana penny stocks, priced $0.50 to $5, ranked by today's percentage change. Cultivators, MSOs (multi-state operators), edibles, REITs with cannabis tenants, and ancillary plays — everything tagged to the cannabis theme. Updated intraday.
| # | Symbol | Company | Sector | Price | Day Chg | Volume |
|---|---|---|---|---|---|---|
| 1 | ISPR | Ispire Technology Inc. Common Stock | Consumer Staples | $1.8200 | +1.68% | 103K |
| 2 | CRON | Cronos Group Inc. Common Share | Healthcare | $2.8500 | +0.35% | 1.3M |
| 3 | OGI | Organigram Global Inc. Common Shares | Healthcare | $1.1400 | 0.00% | 379K |
| 4 | AFCG | Advanced Flower Capital Inc. Common Stock | Financials | $3.7450 | -0.13% | 158K |
| 5 | GRWG | GROW GENERATION CORP | Consumer Discretionary | $1.7750 | -0.28% | 244K |
| 6 | INCR | Intercure Ltd. Ordinary Shares | Healthcare | $1.0600 | -0.94% | 115K |
| 7 | SNDL | Sundial Growers Inc. Common Shares | Consumer Discretionary | $1.4700 | -1.34% | 883K |
| 8 | ACB | Aurora Cannabis Inc. Common Shares | Healthcare | $3.6200 | -1.36% | 791K |
| 9 | HITI | High Tide Inc. Common Shares | Consumer Discretionary | $2.4600 | -1.60% | 413K |
| 10 | VFF | Village Farms International, Inc. Common Shares | Consumer Staples | $2.5300 | -1.94% | 421K |
| 11 | MIRA | MIRA Pharmaceuticals, Inc. Common Stock | Healthcare | $1.0550 | -2.31% | 78K |
| 12 | ARTL | Artelo Biosciences, Inc. Common Stock | Healthcare | $1.4200 | -2.74% | 501K |
| 13 | CGC | Canopy Growth Corporation Common Shares | Healthcare | $1.0800 | -3.57% | 7.8M |
| 14 | GNLN | Greenlane Holdings, Inc. Class A Common Stock | Consumer Discretionary | $3.2400 | -3.57% | 15K |
| 15 | YCBD | cbdMD, Inc. Common Stock | Consumer Staples | $0.7920 | -4.12% | 239K |
| 16 | XXII | 22nd Century Group Inc. | Consumer Staples | $0.5387 | -4.82% | 376K |
| 17 | INM | InMed Pharmaceuticals Inc. Common Shares | Healthcare | $1.5850 | -5.65% | 200K |
| 18 | UGRO | urban-gro, Inc. Common Stock | Industrials | $3.6500 | -8.29% | 75K |
Cannabis at the sub-$5 level is a uniquely policy-driven trade. Federal cannabis is still Schedule I in the US (as of mid-2026), but rescheduling discussions, state legalization progress, banking access (SAFE Banking Act), and DOJ enforcement signals all move the entire group simultaneously. A single news headline can lift or sink the whole sub-$5 cannabis universe in a session.
See also: biotech penny stocks (FDA catalyst trade), penny stocks under $1, trending on Reddit.